George Mason licenses cancer imaging technology to biotech company
July 31, 2026
July 31, 2026
FAIRFAX, Virginia, July 31 -- George Mason University issued the following news:
* * *
George Mason licenses cancer imaging technology to biotech company
*
SonoVanta(tm), a patent-pending contrast agent that improves the precision of cancer margin imaging, is the second technology from George Mason University to be licensed through the Virginia Innovation Partnership Corporation's (VIPC) Lab-to-Launch (L2L) Program, which accelerates the c . . .
* * *
George Mason licenses cancer imaging technology to biotech company
*
SonoVanta(tm), a patent-pending contrast agent that improves the precision of cancer margin imaging, is the second technology from George Mason University to be licensed through the Virginia Innovation Partnership Corporation's (VIPC) Lab-to-Launch (L2L) Program, which accelerates the c . . .